/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | ENTXEntera Bio Ltd. |
|---|---|
| Last close | $2.89 |
| Change % | +0.70% |
| Market cap | $500M |
| P/E | 11.6 |
| Revenue | $42000 |
| Rev growth (YoY) | -76.8% |
| Net income | $-11439000 |
| Net margin | -27235.7% |
| EPS (diluted) | $0.25 |
| Piotroski F-ScoreUNVALIDATED | 2 |
| Altman Z-ScoreUNVALIDATED | 91.45 |
| Beneish M-ScoreUNVALIDATED | — |
| Next earnings | 11-08 → 11-18 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.